Bernd Quadder

696 total citations
9 papers, 68 citations indexed

About

Bernd Quadder is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Bernd Quadder has authored 9 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Physiology. Recurrent topics in Bernd Quadder's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Health and Medical Studies (2 papers). Bernd Quadder is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Health and Medical Studies (2 papers). Bernd Quadder collaborates with scholars based in Germany, United Kingdom and France. Bernd Quadder's co-authors include F Martone, Gerhard Englert, Jeanette Boyd, Günter Ollenschläger, Frank Brunsmann, Ginger Spitzer, Dominique Valeyre, Robert P. Baughman, I. Kopp and Joachim Müller‐Quernheim and has published in prestigious journals such as Respiration, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz and ERJ Open Research.

In The Last Decade

Bernd Quadder

8 papers receiving 61 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernd Quadder Germany 5 43 42 21 14 9 9 68
Tham Le United States 6 17 0.4× 14 0.3× 13 0.6× 13 0.9× 6 0.7× 16 65
Dana V. Wallace United States 3 58 1.3× 84 2.0× 4 0.2× 9 0.6× 4 0.4× 3 102
Eoin Murtagh United Kingdom 2 48 1.1× 23 0.5× 7 0.3× 8 0.6× 4 0.4× 2 56
Daniela Posa Germany 5 25 0.6× 68 1.6× 6 0.3× 5 0.4× 4 0.4× 5 112
Janwillem Kocks Netherlands 8 104 2.4× 80 1.9× 5 0.2× 7 0.5× 4 0.4× 16 130
Lan Le United States 4 47 1.1× 82 2.0× 6 0.3× 8 0.6× 2 0.2× 4 117
Anita Rao India 5 7 0.2× 17 0.4× 28 1.3× 4 0.3× 13 1.4× 7 123
S. Palkonen Spain 2 61 1.4× 72 1.7× 6 0.3× 7 0.5× 9 1.0× 4 100
Kamrul Islam United Kingdom 2 24 0.6× 23 0.5× 10 0.5× 9 0.6× 4 0.4× 3 54
Susan F. Cooper United States 3 14 0.3× 31 0.7× 13 0.6× 7 0.5× 9 1.0× 4 121

Countries citing papers authored by Bernd Quadder

Since Specialization
Citations

This map shows the geographic impact of Bernd Quadder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Quadder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Quadder more than expected).

Fields of papers citing papers by Bernd Quadder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Quadder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Quadder. The network helps show where Bernd Quadder may publish in the future.

Co-authorship network of co-authors of Bernd Quadder

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Quadder. A scholar is included among the top collaborators of Bernd Quadder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Quadder. Bernd Quadder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bonella, Francesco, Björn C. Frye, Andreas Günther, et al.. (2024). Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses: S2k Guideline of the German Respiratory Society. Respiration. 103(12). 1–29.
2.
Skowasch, Dirk, Francesco Bonella, Nikolaus Kneidinger, et al.. (2024). Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Pneumologie. 78(3). 151–166. 1 indexed citations
3.
Behr, Jürgen, Francesco Bonella, Björn C. Frye, et al.. (2023). Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen. Pneumologie. 77(2). 94–119. 6 indexed citations
4.
Storf, Holger, Jürgen Stausberg, Gerhard Kindle, et al.. (2020). Patientenregister für Seltene Erkrankungen in Deutschland: Konzeptpapier der Strategiegruppe „Register“ des Nationalen Aktionsbündnisses für Menschen mit Seltenen Erkrankungen (NAMSE). Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63(6). 761–770. 2 indexed citations
5.
Baughman, Robert P., Jeanette Boyd, F Martone, et al.. (2018). Sarcoidosis: patient treatment priorities. ERJ Open Research. 4(4). 141–2018. 38 indexed citations
6.
Boyd, Jeanette, Robert P. Baughman, Linda Charvoz, et al.. (2018). Sarcoidosis treatment and outcomes: what is most important to patients?. PA5219–PA5219. 4 indexed citations
7.
Englert, Gerhard, et al.. (2009). Patientenbeteiligung an der Leitlinienentwicklung – sind die Patientenorganisationen für diese Aufgabe gerüstet?. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 103(1). 13–16. 5 indexed citations
8.
Brunsmann, Frank, et al.. (2007). Patientenbeteiligung am Programm für Nationale VersorgungsLeitlinien – Stand und Konsequenzen. PubMed. 101(2). 109–116. 8 indexed citations
9.
Kopp, I., et al.. (2007). Auf einheitlicher Basis entscheiden. Medizinische Klinik. 102(6). 474–479. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026